Mai Ya
Hordeum vulgare
Also known as: Barley(English) Barley Sprout(English) Malted Barley(English) Mai Ya(Chinese (Pinyin)) 麦芽(Chinese)
Bakuga麦芽 バクガ Maega麥芽 맥아 Mạch nha
Updated October 23, 2026 · Not yet clinically reviewed
Safety at a glance
Breastfeeding: avoid — suppresses lactation (esp. high dose)
4 recorded drug interactions, 1 major or contraindicated
Contraindications or side effects are listed
No toxicity grade is recorded. Most herbs in the catalogue carry none.
Traditional Chinese Medicine
- Category
- relieving food stagnation
- Temperature
- Neutral
- Taste
- Sweet
- Channels
- Liver,Spleen,Stomach
Functions
Reduces Food Stagnation, improves digestion and strengthens the Stomach; Inhibits lactation; Facilitates the smooth flow of Liver Qi
Traditional uses
Mai Ya (barley sprout, malt) is a mild herb used in Chinese medicine to reduce food stagnation from starchy foods, grains, and fruit, to stimulate appetite in Spleen Qi deficiency with weak digestion, and to treat poorly digested milk in infants. At high doses, it disperses Liver Qi stagnation and is traditionally used to suppress lactation when weaning. It is a gentle, food-grade herb frequently combined with Shan Zha and Shen Qu as the classical digestive tonic trio.
Western herbalism
Properties: carminative, digestive, tonic, demulcent
Pharmacological effects
- Digestive: Enzymes aid carbohydrate and protein digestion; heat-labile amylase makes decoction ~1/3 and browned herb ~1/6 the activity of powder; decoction mildly increased gastric acid and pepsin.
- Hypoglycemic: Oral aqueous extract lowered blood glucose in rabbits and normal humans; a 5% injection from brewing residues (200 mg in rabbits) lowered glucose >40%, reversible in 7 h.
- Miscellaneous (hordenine): Hordenine is sympathomimetic (cardiac stimulation, vasoconstriction, bronchodilation, intestinal inhibition) but content too low and poorly water-soluble to matter.
Source: Zhu YP. Chinese Materia Medica: Chemistry, Pharmacology and Applications. Harwood Academic, 1998, p. 397.
Formulas using this herb
20 of 20 formulas
- Bao Tai Zi Sheng Wan 保胎资生丸 · 30.00000g
- Da He Zhong Yin 大和中饮 · 6.00000g
- Fei Er Wan 肥儿丸 · 150.00000g · assistant
- Jia Wei Ping Wei San 加味平胃散
- Jian Pi Wan 健脾丸 · 30.00000g · deputy
- Jin Jian Fei Er Wan 金鉴肥儿丸
- Li Shi Ban Xia Bai Zhu Tian Ma Tang · 15.00000g
- Qing Wei Tang 清胃汤
- Qu Mai Zhi Zhu Wan 曲糵枳术丸 · 5.00000g
- Shao Yao Yi Yi Ren Tang 芍药薏苡仁汤
- Sheng Yang Chu Shi Tang · 0.90000g
- Tiao Pi San · 9.00000g
- Xiang Fu Wan 香附丸
- Xiang Sha Ping Wei San 香砂平胃散 · 0.90000g
- Xiao Gan Li Pi Tang · 10.00000g
- Xiao Ru Wan 消乳丸 · 30.00000g
- Zha Qu Ping Wei San 楂曲平胃散 · 15.00000g
- Zhen Gan Xi Feng Tang 镇肝熄风汤 · 6.00000g · assistant
- Zhi Shi Xiao Pi Wan 枳实消痞丸 · 6.00000g · assistant
- Zi Sheng Wan 资生丸 · 30.00000g
Botanical
Hordeum vulgare is an annual grass growing 60-120 cm tall, with hollow, jointed culms and flat, linear leaves 10-20 cm long with prominent auricles that clasp the stem. The inflorescence is a dense spike bearing three spikelets at each rachis node (the characteristic barley arrangement). Each spikelet contains one grain (caryopsis) and is often associated with long, stiff awns. In TCM, the germinated grain (Mai Ya) is used, made by sprouting the barley grain.
- Family
- Poaceae
- Pharmaceutical name
- Fructus Hordei Germinatus
- Parts used
- seed
- Plant type
- grass
- Native region
- Palestine
- Conservation status
- not_evaluated
Habitat
Conservation notes
Hordeum vulgare is one of the world most widely cultivated cereal crops. It is a domesticated species. Wild barley (H. vulgare subsp. spontaneum) is found in the Middle East and Central Asia. No conservation concerns for the cultivated form.
Constituents
Hordenine (N,N-dimethyltyramine)
Phenethylamine alkaloid · total alkaloids of germinated barley have been measured at about 42.7 mg hordenine-equivalent per gram of drug by acid-dye colorimetry; that figure is a total-alkaloid estimate expressed as hordenine, not the hordenine content itself
The compound that makes Mai Ya pharmacologically distinctive rather than merely digestive. Hordenine is a functionally selective dopamine D2 receptor agonist; D2 agonism at the anterior pituitary suppresses prolactin release, which is the mechanism of both the traditional lactation-suppressing use at high dose and the modern Chinese use for hyperprolactinaemia. Total alkaloid content of malt varies with sprout length, reported to peak at about 0.75 cm of bud, so the germination endpoint changes the potency of this action.
N-Methyltyramine
Phenethylamine alkaloid
The other dopamine D2 receptor agonist identified in germinated barley and tracked through the brewing process alongside hordenine. It contributes to the same prolactin-suppressing pharmacology and to the total alkaloid figure quoted for the drug.
Gramine
Indole alkaloid
A barley alkaloid quantified together with hordenine by HPLC in the barley chemical-ecology literature. It is principally a seedling and leaf constituent rather than a marker of the malted grain, so it should not be presented as a constituent of the medicinal sprout without batch-specific data.
alpha-Amylase and beta-amylase (diastase)
Starch-hydrolysing enzyme
Induced by germination and the conventional explanation for the food-stagnation indication. Being proteins they are heat-labile: raw or lightly stir-fried Mai Ya retains them, heavily stir-fried (Chao Mai Ya) and charred (Mai Ya Tan) material progressively loses them. This is the practical reason the raw drug is preferred where digestion of starchy food stagnation is the aim.
(1,3;1,4)-beta-D-Glucan
Soluble dietary fibre polysaccharide
The barley fibre with the best human evidence of any constituent here: a meta-analysis of randomised controlled trials found barley beta-glucan lowers LDL cholesterol and total cholesterol. The trials used barley foods at food-scale intakes, not the medicinal dose of Mai Ya, so this supports barley as a food rather than the herb as a lipid drug.
Hordein
Prolamin storage protein (gluten)
Barley's gluten protein. Mai Ya is therefore not gluten-free and is unsafe in coeliac disease and in non-coeliac gluten sensitivity, however it is processed - malting does not remove hordein. Where a sprouted-grain digestive is needed in a coeliac patient, millet sprout (Su Ya / Gu Ya, Setaria italica) is the substitution that avoids the problem.
Maillard reaction products of stir-frying
Thermally generated condensation products
Formed when the sprout is stir-fried, and shown to promote the intestinal absorption of the drug's active ingredients. This gives a chemical reason why processed Mai Ya is not simply a weaker version of the raw drug: stir-frying destroys enzyme activity but improves absorption of the small-molecule actives.
Drug interactions
Breastfeeding and galactagogue therapy (including domperidone and metoclopramide used for milk supply)
Major · suppression of milk production; loss of an established milk supply is not readily reversible · Evidence level: Probable
At the high doses recorded in Chinese practice, conventionally 30 to 120 g, Mai Ya suppresses prolactin secretion and reduces milk production - this is a deliberate therapeutic use for weaning and for breast distension, not an incidental effect. The mechanism is dopamine D2 receptor agonism by hordenine and N-methyltyramine at the pituitary lactotrophs. In hyperprolactinaemic rats, malt of different bud lengths lowered serum prolactin, reduced the number of prolactin-positive pituitary cells and their mRNA expression, and raised hypothalamic dopamine D1 and D2 receptor numbers. Domperidone and metoclopramide raise milk supply by the opposite action, D2 blockade, so the two are directly pharmacodynamically opposed. Note that the small quantities of malt in food and beer are not the same exposure as a 60 to 120 g decoction dose.
Clinical note: Do not prescribe Mai Ya at digestive doses without asking whether the patient is breastfeeding or wishes to be, and avoid it entirely in a mother establishing supply. When used deliberately for weaning or for engorgement, say so explicitly to the patient - and understand the dose direction: low doses are used in Chinese practice to promote lactation while high doses suppress it, so an imprecise dose can produce the opposite of the intended effect.
Antipsychotics and other dopamine D2 antagonists (risperidone, amisulpride, sulpiride, haloperidol, metoclopramide)
Moderate · pharmacodynamic opposition at the D2 receptor; blunting of the drug-induced prolactin rise, and theoretically of antipsychotic effect · Evidence level: Possible
Total barley maiya alkaloids prevented the prolactin elevation caused by antipsychotic drugs in rats and reduced dopamine receptor D2 expression through epigenetic mechanisms, and a separate study showed the alkaloids inhibit prolactin secretion by acting on D2 receptor and protein kinase A targets. This has been proposed as a use rather than a hazard - treating antipsychotic-induced hyperprolactinaemia - but the same D2 agonism is in principle opposed to the antipsychotic's mechanism. All the evidence is rodent and cell-based; no human co-administration study exists.
Clinical note: Do not add or remove Mai Ya at high dose in a psychiatrically stable patient on an antipsychotic without telling the prescriber. If it is being used for drug-induced hyperprolactinaemia, that should be a shared decision with the psychiatrist, not a substitution for reviewing the antipsychotic.
Dopamine agonists (bromocriptine, cabergoline)
Moderate · additive prolactin suppression · Evidence level: Theoretical
Both act at the D2 receptor in the same direction as hordenine, so the effects should add. Hordenine also showed an antiprolactinoma effect in rats through inhibition of MAPK signalling, the same indication cabergoline is used for. No human data on the combination, and the potency of dietary or medicinal hordenine relative to cabergoline is unknown, so this is graded theoretical.
Clinical note: Not a reason to avoid the combination, but check prolactin if a patient on cabergoline or bromocriptine starts high-dose Mai Ya, and do not assume the herb can replace the drug in macroprolactinoma.
Monoamine oxidase inhibitors (phenelzine, tranylcypromine, moclobemide, linezolid)
Theoretical · possible pressor response · Evidence level: Theoretical
Hordenine and N-methyltyramine are N-methylated tyramine derivatives, and tyramine itself is the classic substrate behind the hypertensive reaction to MAO inhibitors. Whether these particular methylated analogues produce a clinically meaningful pressor effect at malt doses has not been tested, so this is an inference from chemical class rather than a documented interaction, and it is recorded here only because the class of compound is the one that matters for MAOI diet advice.
Clinical note: Reasonable to avoid high-dose Mai Ya in a patient on a non-selective MAO inhibitor, alongside the standard tyramine restrictions, rather than to reassure them that the herb is unrelated.
Dosage
| Form | Amount | Frequency | Population | Notes |
|---|---|---|---|---|
| decoction | 10–15 g | daily | adult | 中国药典 2020年版 一部 【麦芽】【用法与用量】10~15g;回乳炒用60g。 — Chinese Pharmacopoeia 2020, Vol. I. Use fried (chao) form to reduce food stagnation. |
Dui yao: classical pairings
Mai Ya + Gu Ya谷芽
Gently reduce food stagnation and awaken the spleen and stomach without harming stomach qi.
Poor appetite and indigestion, especially after illness or with spleen deficiency.
Named pairing — Lü Jingshan, Shi Jinmo Dui Yao
Evidence
Study design on record, not certainty of outcome.
- Systematic review / meta-analysis
- 1
- In vitro / animal
- 6
β-glucan from barley and its lipid-lowering capacity: a meta-analysis of randomized, controlled trials
AbuMweis S S; Jew S; Ames N P · European Journal of Clinical Nutrition · 2010 · systematic review
Systematic review / meta-analysis · Verified
Pooled randomised controlled trials of barley beta-glucan and found significant reductions in total and LDL cholesterol. The only human randomised evidence attaching to any constituent of this drug, but it concerns barley as a food at fibre-scale intakes and does not validate Mai Ya as a lipid-lowering herb.
Total barley maiya alkaloids inhibit prolactin secretion by acting on dopamine D2 receptor and protein kinase A targets
Gong Xiaoyun; Tao Jiahan; Wang Yanming; Wu Jinhu; An Jing; Meng Junhua; Wang Xiong; Chen Yonggang; Zou Jili · Journal of Ethnopharmacology · 2021 · animal
In vitro / animal · Verified
The total alkaloid fraction of barley maiya suppressed prolactin secretion, with the effect traced to dopamine D2 receptor engagement and downstream protein kinase A signalling. This is the mechanistic core of the lactation-suppressing action and it studied Hordeum vulgare malt specifically.
Total Barley Maiya Alkaloids Prevent Increased Prolactin Levels Caused by Antipsychotic Drugs and Reduce Dopamine Receptor D2 via Epigenetic Mechanisms
Cao Yu-Ling; Zhu Li; Zhang Hong; Meng Jun-Hua; Wu Hua-Jun; Wang Xiong; Wu Jin-Hu; Zou Ji-Li; Fang Mao-Sheng; An Jing; Chen Yong-Gang · Frontiers in Pharmacology · 2022 · animal
In vitro / animal · Not yet verified
Barley maiya alkaloids blocked the prolactin rise produced by antipsychotic drugs in rats and downregulated dopamine receptor D2 through epigenetic mechanisms. Basis for the antipsychotic interaction recorded above, in both its therapeutic and its cautionary reading; rodent data only.
Antiprolactinoma Effect of Hordenine by Inhibiting MAPK Signaling Pathway Activation in Rats
Wang Xiong; Guo Run-zhu; Ma Li; Ding Qiao-yan; Meng Jun-hua; Chen Yong-gang; Wu Jin-hu · Evidence-Based Complementary and Alternative Medicine · 2020 · animal
In vitro / animal · Not yet verified
Isolated hordenine, the principal barley malt alkaloid, reduced prolactinoma growth in rats with suppression of MAPK pathway activation. Attributes the drug's endocrine effect to a single identified compound; rat study, no human evidence.
Monitoring of the dopamine D2 receptor agonists hordenine and N-methyltyramine during the brewing process and in commercial beer samples
Sommer Thomas; Dlugash Gelena; Hübner Harald; Gmeiner Peter; Pischetsrieder Monika · Food Chemistry · 2019 · in vitro
In vitro / animal · Not yet verified
Confirms hordenine and N-methyltyramine as dopamine D2 receptor agonists and quantifies them through malting and brewing. Establishes that the D2 activity is a property of germinated barley itself and survives processing, which is what makes the endocrine effect of Mai Ya credible rather than merely traditional.
UPLC-Q-TOF-MS/MS analysis on the chemical composition of malts under different germination cycles and prepared with different processing methods
Zou Jili; Wu Siran; Sheng Bi; An Jing; Meng Junhua; Wang Xiong; Tao Jiahan; Han Wang; Zhao Lin; Xu Hanlin; Chen Yonggang · Fitoterapia · 2023 · in vitro
In vitro / animal · Not yet verified
Compared malt composition across germination times and across raw, stir-fried and charred preparations. Provides the chemical basis for treating raw Mai Ya, Chao Mai Ya and Mai Ya Tan as distinct drugs rather than interchangeable grades of one.
Promoting effect of the Maillard reaction products produced during the stir-frying process of Hordei Fructus Germinatus on the intestinal absorption of active ingredients in Hordei Fructus Germinatus
Wu Lu; Tan Li Xia; Gong Fen Fang; Xia Yu; Chu Rui Ge; Yang Hua Sheng · Food Science and Biotechnology · 2021 · in vitro
In vitro / animal · Not yet verified
Maillard reaction products formed during stir-frying of germinated barley increased the intestinal absorption of the drug's active constituents. Explains why the processed drug is not simply a heat-degraded version of the raw one, and supports the traditional practice of stir-frying for some indications.
Safety
Contraindications
It is not suitable for women in lactation for infant, and its use is cautious in pregnant women.
Source: Xi S, Gong Y. Essentials of Chinese Materia Medica and Medical Formulas. Academic Press/Elsevier, 2017, pp. 189–192.
Side effects
- Clinically no side effects and very low toxicity.
- Animal intoxications when used as cattle feed attributed to maltoxin (candicine), a trace depolarizing muscle relaxant in the fibrous roots; content too low to be toxicologically significant.
Source: Zhu YP. Chinese Materia Medica: Chemistry, Pharmacology and Applications. Harwood Academic, 1998, p. 397.
⚠ Rule-based cautions
These entries come from the deterministic rule tables that gate Verscienta's formula tools: classical pair prohibitions, pregnancy and lactation contraindications, dose ceilings, and drugs outside the Chinese Pharmacopoeia. The botanical-genus entries are different: advisory notes are not part of the safety screen; the Aristolochia genus check is.
Breastfeeding
Avoid suppresses lactation (esp. high dose)
Cultural and historical
Ming Yi Bie Lu · Southern and Northern dynasties
Ben Cao Gang Mu · Ming dynasty
References
- Drugs and Lactation Database (LactMed), National Institute of Child Health and Human Development. Barley. LactMed, NCBI Bookshelf NBK501827. 2024
- Wu Zhiqian; Liang Shuxiao; Zhang Xinyu; Ma Mengting; Sui Zhongquan; Corke Harold. Anti-dyspeptic effects and comparative structural analysis of polysaccharides from hulled and hulless barley-based Hordei Fructus Germinatus. Carbohydrate Polymers. 2026 doi:10.1016/j.carbpol.2026.124892